newsfilter
← Latest News
PR Newswire·

Soliton Announces RAP Treatment Reduces Effects of Liver Fibrosis by 42% in Animal Study

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...